330
Participants
Start Date
December 31, 2013
Primary Completion Date
March 31, 2017
Study Completion Date
October 31, 2017
Placebo group
patient will be managed as recommended by ESC guidelines and follow up will be in accordance to ESC recommendations
Cordiva System (R)
Patients have to answer to 8 specific binary questions based on the main precipitating factors for decompensation and measure their body weight every day. If not they will be contact after two missing measures. Patient will be contact by phone call every month in order to reinforce the initial patient therapeutic education and patient-'s compliance. Patient have access to specific printed documents and to a specific web based platform where he can find some PowerPoint presentation on CHF aetiology, signs and therapy and where he can try to answer to monthly quiz in whom questions are based on key messages about CHF according to guidelines and consensus paper on patient therapeutic education.
BNP heartcheck
Patients had to measure the BNP plasma level using Alere home based BNP device heartcheck in a weekly basis in order to follow this parameter up. In case of clinical signs of CHF or a significant weight increase identified by the tele monitoring or the patient, the nurse will ask to the patient to do an extra measurement of home BNP testing in order to exclude a CHF decompensation (BNP \< 100 pg/ml or remaining stable (\< 30% increase).
Mutualiste Montsouris Institute, Paris
Turin Clinic, Paris
Henri-Mondor Hospital, Créteil
Victor Dupouy Hospital, Argenteuil
Simone Veil Hospital, Eaubonne
Bernard Clinic, Ermont
Sainte Marie Clinic, Osny
Georges Pompidou University Hospital, Paris
Meaux Hospital, Meaux
Poissy-Saint-Germain-en-Laye Hospital, Saint-Germain-en-Laye
Versailles Hospital, Le Chesnay
Sud francilien Hospital, Corbeil-Essonnes
Orsay Hospital, Longjumeau
Centre Hospitalier René DUBOS, Pontoise
Gonesse Hospital, Gonesse
Hôpital NOVO
OTHER